SUSTAIN 6: a post-hoc analysis of the effect of semaglutide on cardiovascular outcomes over time in subjects with type 2 diabetes

被引：0
|
作者：
Jodar, E. [1 ]
Seufert, J. [2 ]
Damgaard, L. H. [3 ]
Holst, A. G. [3 ]
Leiter, L. A. [4 ,5 ]
机构：
[1] Univ Europea Madrid, Hosp Univ Quiron Salud Madrid, Fac Ciencias Salud, Madrid, Spain
[2] Univ Freiburg, Med Ctr, Fac Med, Freiburg, Germany
[3] Novo Nordisk, Soborg, Denmark
[4] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada
[5] Univ Toronto, St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3910
引用
收藏
页码：819 / 819
页数：1
相关论文
共 50 条
  • [1] SUSTAIN 6: A POST-HOC ANALYSIS OF THE EFFECT OF SEMAGLUTIDE ON CARDIOVASCULAR OUTCOMES OVER TIME IN SUBJECTS WITH TYPE 2 DIABETES
    Bellary, S.
    Jodar, E.
    Seufert, J.
    Damgaard, L. H.
    Holst, A. Gaarsdal
    Leiter, L.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2018, 34 : E6 - E7
  • [2] Effect of once-weekly semaglutide on insulin use in subjects with type 2 diabetes: a post hoc analysis of SUSTAIN 6
    Seufert, J.
    Desouza, C.
    Kirk, A. R.
    Lawson, J.
    Lingvay, I.
    Sondergaard, A. L.
    Bain, S. C.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 251 - 252
  • [3] Cardiovascular, Metabolic and Safety Outcomes With Semaglutide by Age: A Post Hoc Analysis of SUSTAIN 6 and PIONEER 6
    Petrie, Mark
    Bain, Stephen
    Hoff, Soren Tetens
    Johansen, Nicklas
    Rasmussen, Soren
    Vilsboell, Tina
    Husain, Mansoor
    [J]. CIRCULATION, 2021, 144
  • [4] Efficacy and safety of semaglutide in subjects with type 2 diabetes by race and ethnicity: a post hoc analysis of the SUSTAIN trials
    Desouza, C.
    Garg, S.
    Cariou, B.
    Furberg, J. K.
    Navarria, A.
    Nayak, G.
    Fonseca, V.
    [J]. DIABETOLOGIA, 2018, 61 : S369 - S370
  • [5] Efficacy and safety of semaglutide in elderly subjects with type 2 diabetes: a post hoc analysis of the SUSTAIN 7 trial
    Aroda, V. R.
    Sugimoto, D.
    Trachtenbarg, D.
    Warren, M.
    Navarria, A.
    Nayak, G.
    Nielsen, M. Abildlund
    Woo, V.
    [J]. DIABETOLOGIA, 2018, 61 : S367 - S367
  • [6] Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6
    Strain, W. David
    Frenkel, Ofir
    James, Martin A.
    Leiter, Lawrence A.
    Rasmussen, Soren
    Rothwell, Peter M.
    Ripa, Maria Sejersten
    Truelsen, Thomas C.
    Husain, Mansoor
    [J]. STROKE, 2022, 53 (09) : 2749 - 2757
  • [7] Effect of semaglutide on MACE by baseline kidney function in participants with type 2 diabetes and high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc analysis
    Rossing, P.
    Bain, S.
    Bosch-Traberg, H.
    Frenkel, O.
    Heerspink, H. L.
    Rasmussen, S.
    Mellbin, L.
    [J]. DIABETOLOGIA, 2022, 65 (SUPPL 1) : S24 - S25
  • [8] Effect of semaglutide versus placebo on cardiovascular outcomes by baseline HbA1c: SUSTAIN 6 and PIONEER 6 post hoc analysis
    Mellbin, L. G.
    Bhatt, D. L.
    David, J. -P.
    Petrie, M. C.
    Rasmussen, S.
    Schytz, P. A.
    Vilsboll, T.
    [J]. DIABETOLOGIA, 2022, 65 (SUPPL 1) : S304 - S305
  • [9] Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity: A Post Hoc Analysis of the SUSTAIN Trials
    DeSouza, Cyrus
    Cariou, Bertrand
    Garg, Satish
    Lausvig, Nanna
    Navarria, Andrea
    Fonseca, Vivian
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (02): : 543 - 556
  • [10] Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial
    Leiter, Lawrence A.
    Bain, Stephen C.
    Hramiak, Irene
    Jodar, Esteban
    Madsbad, Sten
    Gondolf, Theis
    Hansen, Thomas
    Holst, Ingrid
    Lingvay, Ildiko
    [J]. CARDIOVASCULAR DIABETOLOGY, 2019, 18 (1)
12345